Found 91 matching trials
Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients PHASE2 Severe ill Patients will be enrolled in the study (n=310) after duly filled...
Show More Location
Dow University of Health Sciences
Learn More & Join Trial
A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) PHASE3 This is a prospective open-label, uncontrolled, single-blind, pilot clinica...
Show More Location
University of Alberta
Learn More & Join Trial
Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention PHASE2 To examine the prevalence of humoral immunodeficiency in patients with Chro...
Show More Location
Rochester Regional Health Ctr for Clinical Research - Alexander Park
Learn More & Join Trial
Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration PHASE2 This study will evaluate visual improvement in patients treated with Immune...
Show More Location
Universitatsklinikum Aachen, Augenklinik
Learn More & Join Trial
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study) PHASE3 The objective of this study is to assess the efficacy, safety, tolerability...
Show More Learn More & Join Trial
Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis PHASE2 The purpose of this study is to determine whether Hizentra is a safe and ef...
Show More Location
Phoenix Neurological Associates
Learn More & Join Trial
Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection PHASE4 Thrombocytopenia occurs when a person's blood has a decreased number of pla...
Show More Location
New York Presbyterian Hospital (Cornell)
Learn More & Join Trial
A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants PHASE1 The purpose of the study is to assess the tolerability, safety, and pharmac...
Show More Location
Clinical Pharmacology of Miami, Inc
Learn More & Join Trial
Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) PHASE4 This multicenter, open-label, parallel-arm, non-randomized study is designe...
Show More Location
Clinical Research Center of Alabama
Learn More & Join Trial
Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases PHASE2 This study proposes the use of a reduced intensity chemotherapy/radiation t...
Show More Location
Columbia University Medical Center
Learn More & Join Trial